This process further contributes to the maintenance of the immune microenvironment of SS through the release of DAMPs, such as IL-33 and HMGB1, ultimately leading to impaired glandular function and tissue fibrosis (24). The gene discussed is HMGB1; the disease is synovial sarcoma.